Xu, Wei <br/><br/>
High-dose methylprednisolone can induce remissions in patients with fludarabine-refractory chronic lymphocytic leukaemia.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Aug 2010 
 - 2145-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2010.04.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Disease Progression<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Male<br/>Methylprednisolone--administration & dosage<br/>Middle Aged<br/>Remission Induction--methods<br/>Treatment Outcome<br/>Vidarabine--analogs & derivatives